These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 6927548

  • 1. Pharmacokinetics and echocardiographic effects of digoxin in low birth weight infants with left-to-right shunting due to patent ductus arteriosus.
    Warburton D, Bell EF, Oh W.
    Dev Pharmacol Ther; 1980; 1(2-3):189-200. PubMed ID: 6927548
    [Abstract] [Full Text] [Related]

  • 2. Effects of indomethacin on digoxin pharmacokinetics in preterm infants.
    Koren G, Zarfin Y, Perlman M, MacLeod SM.
    Pediatr Pharmacol (New York); 1984; 4(1):25-30. PubMed ID: 6739184
    [Abstract] [Full Text] [Related]

  • 3. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L.
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of digoxin in low-birth-weight infants.
    Collins-Nakai RL, Schiff D, Ng PK.
    Dev Pharmacol Ther; 1982 Jan; 5(1-2):86-97. PubMed ID: 7151640
    [Abstract] [Full Text] [Related]

  • 5. Value of systolic time intervals in the diagnosis of large patent ductus arteriosus in fluid-restricted and mechanically ventilated preterm infants.
    Heitz F, Fouron JC, van Doesburg NH, Bard H, Teasdale F, Chessex P, Davignon A.
    Pediatrics; 1984 Dec; 74(6):1069-74. PubMed ID: 6504626
    [Abstract] [Full Text] [Related]

  • 6. Echocardiographic characteristics of premature infants with patient ductus arteriosus.
    Johnson GL, Breart GL, Gewitz MH, Brenner JI, Lang P, Dooley KJ, Ellison RC.
    Pediatrics; 1983 Dec; 72(6):864-71. PubMed ID: 6646930
    [Abstract] [Full Text] [Related]

  • 7. The 24-hour serum digoxin level as a prognosticator of dosage requirement in low-birth-weight (LBW) infants.
    Ng PK, Collins-Nakai RL.
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):71-9. PubMed ID: 6648043
    [Abstract] [Full Text] [Related]

  • 8. Complications associated with digoxin therapy in low-birth weight infants.
    Johnson GL, Desai NS, Pauly TH, Cunningham MD.
    Pediatrics; 1982 Apr; 69(4):463-5. PubMed ID: 7070893
    [Abstract] [Full Text] [Related]

  • 9. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
    Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM.
    J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
    [Abstract] [Full Text] [Related]

  • 10. Serum digoxin levels in neonates whose weights are less than 1,500 grams.
    Patterson MW, Reid G, Sandor GG.
    Pediatr Pharmacol (New York); 1982 Apr; 2(3):217-21. PubMed ID: 7162876
    [Abstract] [Full Text] [Related]

  • 11. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus.
    Van Overmeire B, Touw D, Schepens PJ, Kearns GL, van den Anker JN.
    Clin Pharmacol Ther; 2001 Oct; 70(4):336-43. PubMed ID: 11673749
    [Abstract] [Full Text] [Related]

  • 12. Association of patent ductus arteriosus and phototherapy in infants weighing less than 1000 grams.
    Barefield ES, Dwyer MD, Cassady G.
    J Perinatol; 1993 Oct; 13(5):376-80. PubMed ID: 8263622
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
    Stewart CD, Morris BH, Huseby V, Kennedy KA, Moya FR.
    J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
    [Abstract] [Full Text] [Related]

  • 14. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hunt CE.
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [Abstract] [Full Text] [Related]

  • 15. Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction.
    Rakza T, Magnenant E, Klosowski S, Tourneux P, Bachiri A, Storme L.
    J Pediatr; 2007 Dec; 151(6):624-8. PubMed ID: 18035142
    [Abstract] [Full Text] [Related]

  • 16. Skin reflectance changes in preterm infants with patent ductus arteriosus.
    De Felice C, Mazzieri S, Pellegrino M, Del Pasqua A, Toti P, Bagnoli F, Rosati E, Latini G.
    Early Hum Dev; 2004 Jun; 78(1):45-51. PubMed ID: 15177671
    [Abstract] [Full Text] [Related]

  • 17. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S, Limrungsikul A, Khowsathit P.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [Abstract] [Full Text] [Related]

  • 18. Digoxin therapy in low-birth-weight infants with patent ductus arteriosus.
    Berman W, Dubynsky O, Whitman V, Friedman Z, Maisels MJ.
    J Pediatr; 1978 Oct; 93(4):652-5. PubMed ID: 702246
    [Abstract] [Full Text] [Related]

  • 19. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M, Donovan T, Tudehope D, Woodgate P, Collie LA, Charles B.
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E, Tejedor JC, Quero J, Pérez Rodríguez J, Agustí B, Castro J, García Frías E.
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.